Skip to main content

Table 3 Demographics and baseline characteristics by treatment group1.

From: Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial

Clinical data Control group Experimental group pvalue
Gender (male/female) 9/3 9/2 1.0a
Age, years 58.5 (19.2) 53.3 (15.2) .42b
Most common clinical form (%) LL# (92%) LL# (73%) .31a
Years since leprosy diagnostic 38.4 (16.0) 39.1 (15.7) .91b
Years free of M. leprae 14.2 (5.6) 14.3 (3.9) .97b
Ulcers duration (months) 71.7 (82.2) 123.3 (159.6) .28b
Ulcers area 5.3 (9.2) 4.2 (5.9) .70b
Ulcers depth 6.3 (5.4) 6.2 (5.1) .96b
PUSH score 9.7 (3.4) 9.6 (3.3) .96c
Adapted footwear usage 5 subjects 4 subjects 1.0a
  1. 1Values are means (SDs) unless otherwise indicated. # LL = Lepromatous leprosy.
  2. a As determined by Fisher's exact test.
  3. bAs determined by an independent 2-sample t test.
  4. cAs determined by the Mann-Whitney U test.
\